Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chun Y. Fong"'
Autor:
Mathew Wallis, Simon D. Bodek, Jacob Munro, Haloom Rafehi, Mark F. Bennett, Zimeng Ye, Amy Schneider, Fiona Gardiner, Giulia Valente, Emma Murdoch, Eloise Uebergang, Jacquie Hunter, Chloe Stutterd, Aamira Huq, Lucinda Salmon, Ingrid Scheffer, Dhamidhu Eratne, Stephen Meyn, Chun Y. Fong, Tom John, Saul Mullen, Susan M. White, Natasha J. Brown, George McGillivray, Jesse Chen, Chris Richmond, Andrew Hughes, Emma Krzesinski, Andrew Fennell, Brian Chambers, Renee Santoreneos, Anna Le Fevre, Michael S. Hildebrand, Melanie Bahlo, John Christodoulou, Martin Delatycki, Samuel F. Berkovic
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-14 (2024)
Abstract Background Significant recent efforts have facilitated increased access to clinical genetics assessment and genomic sequencing for children with rare diseases in many centres, but there remains a service gap for adults. The Austin Health Adu
Externí odkaz:
https://doaj.org/article/3db51aa91e4d4222a42db0a751cb4260
Autor:
Phillip C. Nguyen, Ing Soo Tiong, Anthony P. Schwarer, David Kliman, Chun Y Fong, Kate Manos, David J. Curtis, Andrew H. Wei
Publikováno v:
Internal Medicine Journal. 51:1954-1958
The benefits of non-myeloablative stem cell transplant in older patients with acute myeloid leukaemia are unclear. We compare the long-term outcomes of this regimen in those aged 55-65 years in first remission with a chemotherapy only cohort that ach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e347033b28912bd33f92706bc2f7350e
https://doi.org/10.1111/imj.15564
https://doi.org/10.1111/imj.15564
Publikováno v:
Pathology. 55:S37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f0667fa829867ce6bd34c896ef8b69d
https://doi.org/10.1016/j.pathol.2022.12.124
https://doi.org/10.1016/j.pathol.2022.12.124
Autor:
Anthony P. Schwarer, Mark Droogleever, Stephen B. Ting, Chong Chyn Chua, Ing Soo Tiong, Jasmine Singh, Chun Y Fong, Lan Zhang, Andrew Grigg, Andrew H. Wei, Andrew Lim
Publikováno v:
Leukemia & Lymphoma. 61:848-854
Recent regulatory approval of midostaurin, a FLT3 targeting small molecular inhibitor, will likely lead to increased use of midostaurin in combination with intensive chemotherapy for patients with FLT3-mutant AML. Translation of clinical trial result
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bb2087be6cc0046bc40a08238f4f86b
https://doi.org/10.1080/10428194.2019.1691192
https://doi.org/10.1080/10428194.2019.1691192
Autor:
Chong C, Chua, Andrew, Grigg, Jasmine, Singh, Mark P, Droogleever, Lan, Zhang, Andrew, Lim, Chun Y, Fong, Stephen B, Ting, Anthony, Schwarer, Ing S, Tiong, Andrew H, Wei
Publikováno v:
Leukemialymphoma. 61(4)
Recent regulatory approval of midostaurin, a FLT3 targeting small molecular inhibitor, will likely lead to increased use of midostaurin in combination with intensive chemotherapy for patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d4614a7a87bd8f960bb7c07527ca1f9b
https://pubmed.ncbi.nlm.nih.gov/31752581
https://pubmed.ncbi.nlm.nih.gov/31752581
Autor:
Andrew B M, Lim, Cameron, Curley, Chun Y, Fong, Ian, Bilmon, Ashanka, Beligaswatte, Duncan, Purtill, Bartlomiej, Getta, Anne M, Johnston, Tasman, Armytage, Marnie, Collins, Kate, Mason, Katherine, Fielding, Matthew, Greenwood, John, Gibson, Mark, Hertzberg, Matthew, Wright, Ian, Lewis, John, Moore, David, Curtis, Jeff, Szer, Glen, Kennedy, David, Ritchie
Publikováno v:
Internal medicine journal. 48(3)
We sought to determine factors associated with the overall survival from relapse (OSR) of acute myeloid leukaemia (AML) after allogeneic haemopoietic stem cell transplantation (alloHSCT) and the effect of first salvage therapy and subsequent graft-ve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::32cb407aa2ea89fa794b15d9800eda14
https://pubmed.ncbi.nlm.nih.gov/28628276
https://pubmed.ncbi.nlm.nih.gov/28628276